PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1577236
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1577236
Ventricular Assist Devices Market Forecasts to 2030 - Global Analysis By Product, Design, Type of Flow, Application, End User and By Geography
According to Stratistics MRC, the Global Ventricular Assist Devices Market is accounted for $3.6 billion in 2024 and is expected to reach $10.7 billion by 2030 growing at a CAGR of 19.6% during the forecast period. Mechanical pumps called Ventricular Assist Devices (VADs) help the ventricles pump blood to the body, hence supporting heart function. Patients who are not candidates for transplant surgery, have significant heart failure, or are awaiting a heart transplant frequently utilize them. VADs can be inserted into one or both ventricles, the most frequent being the left ventricle (LVAD), right ventricle (RVAD), or both (BiVAD). They raise the standard of living for patients, increase blood flow, and lessen cardiac strain.
According to the American Heart Association (AHA), the prevalence of heart failure is expected to increase at a significant growth rate by 2030 in the U.S., and is projected to reach over 8 million patients. In 2020, globally, more than 5.5 million individuals were affected by heart failure. Old-age people are at high risk of HF. Therefore, the increasing geriatric population has also been fueling the disease prevalence.
Market Dynamics:
Driver:
Global prevalence of heart failure
In wealthy nations, heart failure affects 1-2% of the population; by 2030, nearly 8 million Americans may be affected, according to forecasts. The rise in heart failure instances is a major factor driving the need for VADs. Moreover chronic illnesses that are common in aging populations, such as diabetes and hypertension, are the primary cause of the rise in heart failure patients Hence the demand for VADs is increased by the scarcity of available cardiac donors.
Restraint:
Risks associated with implantation
Increased bleeding risks are one of the surgical consequences associated with VAD implants, and anticoagulant medication may make matters worse. External parts such as controllers and power supplies can act as sites of entry for infections, which can cause serious problems and higher post-transplant mortality rates. Thrombosis is one device-related consequence that requires cautious anticoagulation level monitoring because it might cause strokes or pump failure. Furthermore, right ventricular dysfunction brought on by an increased stress on the heart may complicate patient outcomes and necessitate further procedures.
Opportunity:
Continuous innovations in VAD technology
Progress in technology has resulted in more robust and compact devices, enhancing the comfort and mobility of patients. Advances in biocompatibility have lowered risks of thrombosis and infections, which has lowered obstacles to patient adoption. VAD therapy is now more widely available to a larger range of patients thanks to the less invasive nature of miniaturization, which also makes recovery times quicker and implantation processes simpler.
Threat:
Inadequate reimbursement policies and insurance coverage
VADs require implantation procedures as well as post-operative care, which can be costly. Patients may be discouraged from choosing VAD therapy if they have to pay large out-of-pocket costs due to inadequate insurance coverage. Insufficient access to care can lead to postponed or abandoned medical interventions, deteriorating health outcomes and increasing long-term healthcare expenses, ultimately decreasing market demand for VADs.
Covid-19 Impact:
The COVID-19 pandemic negatively impacted the Ventricular Assist Devices (VAD) market by causing significant delays in elective surgeries and a reduction in device utilization. Lockdowns and travel restrictions led to fewer VAD transplants, as many patients postponed seeking treatment due to safety concerns. This resulted in decreased demand for VADs, affecting revenue for manufacturers and healthcare providers. However, as restrictions eased, a rebound in patient visits and procedures is anticipated, potentially revitalizing market growth in subsequent years.
The biventricular assist devices segment is expected to be the largest during the forecast period
The biventricular assist devices segment is expected to be the largest during the forecast period owing to increased demand and advancements in BiVAD technology, such as pneumatically driven systems that improve device performance and usefulness in total artificial heart (TAH) transplant scenarios. Better hemodynamic support, improved quality of life, increased survival rates, and more patient and physician acceptance are all achieved by BiVADs.
The bridge-to-transplant segment is expected to have the highest CAGR during the forecast period
The bridge-to-transplant segment is expected to have the highest CAGR during the forecast period owing to its vital function in keeping patients stable while they await heart transplants. VADs improve patient outcomes by providing necessary mechanical support for a period of two to six months. A greater understanding of the effectiveness of BTT therapy promotes its broader use in the treatment of heart failure.
Region with largest share:
North America is expected to have the largest market share over the projection period due to the growing rate of heart failure in North America combined with technological developments in medical devices has raised demand for valve assist devices (VADs) as destination and bridge-to-transplant therapies. Moreover VADs offer a vital substitute in the event that there are insufficient donor hearts available for transplantation, assisting patients in surviving either permanently or while they wait for a transplant.
Region with highest CAGR:
Asia Pacific is anticipated to witness the highest rate of growth during the forecast period owing to increased investment in modern medical technology and healthcare infrastructure by China, India, Japan, and South Korea is contributing to the growing use of VADs. The need for sophisticated heart failure management solutions is being driven by rising awareness and enhanced diagnostic capabilities. The Asia Pacific VAD market is expanding as a result of technological developments that include the development of smaller, more effective devices with fewer issues.
Key players in the market
Some of the key players in Ventricular Assist Devices Market include Abiomed Inc., BiVACOR Inc, Abbott Laboratories, Berlin Heart GmbH, Calon Cardio, Medtronic PLC, SynCardia Systems LLC, Terumo Corporation, Jarvik Heart Inc., ReliantHeart, Inc. and Sun Medical Technology Research Corp .
Key Developments:
In September 2024, Abbott announced the findings of a new survey among leading infectious disease experts around the world on the state of pandemic preparedness and found that while most agree that preparation has improved since the COVID-19 pandemic.
In September 2024, Abbott announced U.S. availability of Lingo(TM), the company's first continuous glucose monitoring system available without a prescription. Lingo is based on Abbott's world-leading FreeStyle Libre(R) continuous glucose monitoring technology1, now used by more than 6 million people with diabetes globally.
In September 2024, Medtronic plc announced at the North American Spine Society (NASS) 39th Annual Meeting in Chicago the commercial launch of several software, hardware, and imaging innovations.
Products Covered:
- Left Ventricular Assist Device
- Right Ventricular Assist Device
- Biventricular Assist Device
- Total Artificial Heart
Designs Covered:
- Implantable Ventricular Assist Devices
- Transcutaneous Ventricular Assist Devices
Type of Flows Covered:
- Pulsatile Flow VAD
- Continuous Flow VAD
Applications Covered:
- Bridge-to-Transplant
- Destination Therapy
- Bridge-to-Recovery
- Bridge-to-Candidacy
End Users Covered:
- Hospitals
- Cardiac Surgery Centers
- Home Care Agencies
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Product Analysis
- 3.7 Application Analysis
- 3.8 End User Analysis
- 3.9 Emerging Markets
- 3.10 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Ventricular Assist Devices Market, By Product
- 5.1 Introduction
- 5.2 Left Ventricular Assist Device
- 5.3 Right Ventricular Assist Device
- 5.4 Biventricular Assist Device
- 5.5 Total Artificial Heart
6 Global Ventricular Assist Devices Market, By Design
- 6.1 Introduction
- 6.2 Implantable Ventricular Assist Devices
- 6.3 Transcutaneous Ventricular Assist Devices
7 Global Ventricular Assist Devices Market, By Type of Flow
- 7.1 Introduction
- 7.2 Pulsatile Flow VAD
- 7.3 Continuous Flow VAD
8 Global Ventricular Assist Devices Market, By Application
- 8.1 Introduction
- 8.2 Bridge-to-Transplant
- 8.3 Destination Therapy
- 8.4 Bridge-to-Recovery
- 8.5 Bridge-to-Candidacy
9 Global Ventricular Assist Devices Market, By End User
- 9.1 Introduction
- 9.2 Hospitals
- 9.3 Cardiac Surgery Centers
- 9.4 Home Care Agencies
- 9.5 Other End Users
10 Global Ventricular Assist Devices Market, By Geography
- 10.1 Introduction
- 10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
- 10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
- 10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
- 10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
- 10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa
11 Key Developments
- 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 11.2 Acquisitions & Mergers
- 11.3 New Product Launch
- 11.4 Expansions
- 11.5 Other Key Strategies
12 Company Profiling
- 12.1 Abiomed Inc.
- 12.2 BiVACOR Inc.
- 12.3 Abbott Laboratories
- 12.4 Berlin Heart GmbH
- 12.5 Calon Cardio
- 12.6 Medtronic PLC
- 12.7 SynCardia Systems LLC
- 12.8 Terumo Corporation
- 12.9 Jarvik Heart Inc.
- 12.10 ReliantHeart, Inc.
- 12.11 Sun Medical Technology Research Corp
List of Tables
- Table 1 Global Ventricular Assist Devices Market Outlook, By Region (2022-2030) ($MN)
- Table 2 Global Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
- Table 3 Global Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
- Table 4 Global Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
- Table 5 Global Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
- Table 6 Global Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
- Table 7 Global Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
- Table 8 Global Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
- Table 9 Global Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
- Table 10 Global Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
- Table 11 Global Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
- Table 12 Global Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
- Table 13 Global Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
- Table 14 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
- Table 15 Global Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
- Table 16 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
- Table 17 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
- Table 18 Global Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
- Table 19 Global Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
- Table 20 Global Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
- Table 21 Global Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
- Table 22 Global Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
- Table 23 North America Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
- Table 24 North America Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
- Table 25 North America Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
- Table 26 North America Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
- Table 27 North America Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
- Table 28 North America Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
- Table 29 North America Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
- Table 30 North America Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
- Table 31 North America Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
- Table 32 North America Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
- Table 33 North America Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
- Table 34 North America Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
- Table 35 North America Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
- Table 36 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
- Table 37 North America Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
- Table 38 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
- Table 39 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
- Table 40 North America Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
- Table 41 North America Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
- Table 42 North America Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
- Table 43 North America Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
- Table 44 North America Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
- Table 45 Europe Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
- Table 46 Europe Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
- Table 47 Europe Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
- Table 48 Europe Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
- Table 49 Europe Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
- Table 50 Europe Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
- Table 51 Europe Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
- Table 52 Europe Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
- Table 53 Europe Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
- Table 54 Europe Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
- Table 55 Europe Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
- Table 56 Europe Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
- Table 57 Europe Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
- Table 58 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
- Table 59 Europe Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
- Table 60 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
- Table 61 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
- Table 62 Europe Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
- Table 63 Europe Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
- Table 64 Europe Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
- Table 65 Europe Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
- Table 66 Europe Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
- Table 67 Asia Pacific Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
- Table 68 Asia Pacific Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
- Table 69 Asia Pacific Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
- Table 70 Asia Pacific Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
- Table 71 Asia Pacific Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
- Table 72 Asia Pacific Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
- Table 73 Asia Pacific Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
- Table 74 Asia Pacific Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
- Table 75 Asia Pacific Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
- Table 76 Asia Pacific Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
- Table 77 Asia Pacific Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
- Table 78 Asia Pacific Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
- Table 79 Asia Pacific Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
- Table 80 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
- Table 81 Asia Pacific Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
- Table 82 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
- Table 83 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
- Table 84 Asia Pacific Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
- Table 85 Asia Pacific Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
- Table 86 Asia Pacific Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
- Table 87 Asia Pacific Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
- Table 88 Asia Pacific Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
- Table 89 South America Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
- Table 90 South America Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
- Table 91 South America Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
- Table 92 South America Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
- Table 93 South America Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
- Table 94 South America Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
- Table 95 South America Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
- Table 96 South America Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
- Table 97 South America Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
- Table 98 South America Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
- Table 99 South America Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
- Table 100 South America Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
- Table 101 South America Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
- Table 102 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
- Table 103 South America Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
- Table 104 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
- Table 105 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
- Table 106 South America Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
- Table 107 South America Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
- Table 108 South America Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
- Table 109 South America Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
- Table 110 South America Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
- Table 111 Middle East & Africa Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
- Table 112 Middle East & Africa Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
- Table 113 Middle East & Africa Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
- Table 114 Middle East & Africa Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
- Table 115 Middle East & Africa Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
- Table 116 Middle East & Africa Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
- Table 117 Middle East & Africa Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
- Table 118 Middle East & Africa Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
- Table 119 Middle East & Africa Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
- Table 120 Middle East & Africa Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
- Table 121 Middle East & Africa Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
- Table 122 Middle East & Africa Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
- Table 123 Middle East & Africa Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
- Table 124 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
- Table 125 Middle East & Africa Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
- Table 126 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
- Table 127 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
- Table 128 Middle East & Africa Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
- Table 129 Middle East & Africa Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
- Table 130 Middle East & Africa Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
- Table 131 Middle East & Africa Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
- Table 132 Middle East & Africa Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
